Dashboard
Pfizer Inc.
PFENYSEFor informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Universal block
Live market data + trailing fundamentals.
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Nov 16Ownership changeSEC
Form 4 insider transaction filing by Pfizer executive or director.
- Nov 3Ownership changeSEC
Pfizer Inc. Form 4 insider transaction filing dated 2026-11-03.
- Nov 3LeadershipSEC
8-K reports changes in directors or officers under item 5.02.
- Nov 3Financial resultsSEC
Pfizer files 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.
- Nov 2DealFederal award
Pfizer awarded $11.11B DoD contract for COVID-19 vaccine production.
$11.1B - Oct 16Ownership changeSEC
Pfizer Inc. filed SEC Form 4 reporting an insider transaction.
- Oct 14Ownership changeSEC
SEC Form 4 insider transaction filing.
- Oct 1Ownership changeSEC
Form 4 insider transaction filing dated 2026-10-01.
- Sep 29Ownership changeSEC
SEC Form 4 insider transaction filing.
- Sep 29Ownership changeSEC
SEC Form 4 insider transaction filing.
- Sep 29Ownership changeSEC
Form 4 insider transaction filing for Pfizer Inc.
- Sep 29Ownership changeSEC
SEC Form 4 insider transaction filing.
- Sep 29Ownership changeSEC
SEC Form 4 insider transaction filing.
- Sep 29Ownership changeSEC
SEC Form 4 insider transaction filing dated 2026-09-29.
- Sep 16Ownership changeSEC
SEC Form 4 insider ownership change filing.
- Sep 1Ownership changeSEC
SEC Form 4 insider ownership report filed.
- Aug 27DealFederal award
Pfizer awarded $11.11B DoD contract for COVID-19 vaccine production (award W15QKN21C0012).
$11.1B - Aug 17Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership.
- Aug 12Ownership changeSEC
SEC Form 4 insider transaction filing reporting change in beneficial ownership.
- Aug 6Ownership changeSEC
Pfizer insider filed SEC Form 4 reporting transaction.
Not financial advice — research and opinion only. Disclosures